Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company’s leading alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which prov...
Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company’s leading alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which provide the opportunity to personalize treatment and optimize patient outcomes.

List your booth number for exhibitions, ask us

Contact Viewpoint Molecular Targeting and get a quotation

Viewpoint Molecular Targeting is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of [212Pb]VMT-A-NET bulk with DMF offered by Viewpoint Molecular Targeting

Find a price of [203PB]VMT-A-NET SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY AGENT bulk with DMF offered by Viewpoint Molecular Targeting